Onco Solution

OncoSolution is a South Korean biotechnology company dedicated to advancing precision oncology through the integration of companion diagnostics (CDx) and targeted therapeutics. The company focuses on developing small molecule inhibitors that target specific genetic drivers of cancer, particularly in non-small cell lung cancer and other solid tumors. By utilizing a proprietary biomarker discovery platform, OncoSolution aims to identify patients most likely to respond to their therapies, thereby increasing clinical success rates. Their current pipeline includes several preclinical candidates designed to overcome resistance mechanisms in existing treatments.